Drugs / Virulizin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00040092 | Jul 2002 → Jul 2005 | malignant pancreatic neoplasm | Aptose Biosciences Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Virulizin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00040092 ↗ |
| Route | Intramuscular | “sterile preparation for IM injection” NCT00040092 ↗ |